Patterns of Long-term Cancer Survivorship Care in a National Cancer Institute-Designated Comprehensive Cancer Center

被引:3
|
作者
Miller, Kenneth [1 ]
Mehta, Rutika [2 ]
Abraham, Joseph [3 ]
Opneja, Aman [2 ]
Jain, Rohit K. [2 ]
机构
[1] Sinai Hosp Baltimore, Div Hematol Oncol, Baltimore, MD USA
[2] Sinai Hosp Baltimore, Dept Internal Med, Baltimore, MD USA
[3] Apex Epidemiol, Baltimore, MD USA
关键词
cancer survivor; surveillance; gaps in care; BREAST-CANCER; ONCOLOGISTS; PHYSICIAN; POPULATION; ATTITUDES; QUALITY; SEASONS; WILL;
D O I
10.1097/COC.0000000000000217
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: The majority of the cancer survivors in the United States are 5 or more years beyond their diagnosis. The follow-up care of these individuals remains a major concern for survivors and for the cancer care system. The purpose of this study was to characterize long-term cancer survivors' visits at a National Cancer Institute-designated comprehensive cancer center. Materials and Methods: We abstracted electronic medical record data for 18,882 unique patients' visits during 2010 to determine the distribution of the number of years of survival after the initial cancer diagnosis. We then reviewed 374 patient visits during a randomly selected week in April 2010 to determine whether patients were seen for treatment of a new diagnosis of cancer, a residual or recurrent cancer, for a second or secondary cancer, or for cancer survivorship care while not actively receiving treatment (other than adjuvant hormonal therapy). Results: In the 1-year group of 18,882 unique patients visits the percentage of patients who were <1, 1 to 5, 6 to 10, and >10 years postdiagnosis were 18.7%, 48.7%, 18.9%, and 13.8%, respectively. During the selected week, 74% of the total office visits were with patients who were being actively treated for a new cancer, relapse, or a second cancer, whereas 24% were not being seen for treatment of an active malignancy. The percentage of total office visits with patients who were <6, 6 to 10, or >10 years postdiagnosis and had completed their initial treatment were 21.4%, 3.7%, and 1%, respectively. Approximately 5% of oncology office visits were with cancer survivors who were 5 or more years postdiagnosis and not receiving treatment. Conclusions: In a database of over 18,000 unique patients who were seen at a major cancer center in 2010, approximately 68% were 5 or less and 32% were 6 or more years postdiagnosis. A review of the medical oncology notes in a random sample of cases of oncology visits demonstrated that approximately 5% of office visits were with long-term cancer survivors who were >5 years postdiagnosis and not receiving active treatment. Implications for Cancer Survivors: Cancer survivors often indicate a preference to receive long-term follow-up care from their oncologist. These findings suggest that long-term cancer survivorship care represents only a small component of care at a comprehensive cancer center and also that alternative models for long-term survivorship health care need to be considered.
引用
收藏
页码:639 / 643
页数:5
相关论文
共 50 条
  • [1] Oncologists' perspectives on concurrent palliative care in a National Cancer Institute-designated comprehensive cancer center
    Bakitas, Marie
    Lyons, Kathleen Doyle
    Hegel, Mark T.
    Ahles, Tim
    [J]. PALLIATIVE & SUPPORTIVE CARE, 2013, 11 (05) : 415 - 423
  • [2] Management of Occult Primary Breast Cancer at a National Cancer Institute-Designated Comprehensive Cancer Center
    Fayanju, Oluwadamilola
    Jeffe, Donna
    Margenthaler, Julie
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2013, 20 : 40 - 40
  • [3] Setting the bar: compliance with ovarian cancer quality indicators at a National Cancer Institute-designated Comprehensive Cancer Center
    Liang, Margaret I.
    ElNaggar, Adam C.
    Nekkanti, Silpa
    O'Malley, David M.
    Hade, Erinn M.
    Copeland, Larry J.
    Fowler, Jeffrey M.
    Salani, Ritu
    Backes, Floor J.
    Cohn, David E.
    [J]. GYNECOLOGIC ONCOLOGY, 2015, 138 (03) : 689 - 693
  • [4] Cancer disparities among sexual and gender minority patients at a National Cancer Institute-Designated Comprehensive Cancer Center
    Zamani, Shahrzad A.
    Perez-Morales, Jaileene
    Miller, Jarred D.
    Schabath, Matthew B.
    [J]. CANCER RESEARCH, 2023, 83 (07)
  • [5] Improving the Time to Activation of New Clinical Trials at a National Cancer Institute-Designated Comprehensive Cancer Center
    Williams, Erin
    Brown, Timothy J.
    Griffith, Patrice
    Rahimi, Asal
    Oilepo, Rhonda
    Hammers, Hans
    Laetsch, Theodore W.
    Currykosky, Penny
    Partridge, Susan
    Beg, Muhammad S.
    [J]. JCO ONCOLOGY PRACTICE, 2020, 16 (04) : 166 - +
  • [6] Incorporating a compact proton therapy unit into an existing National Cancer Institute-designated comprehensive cancer center
    Mansur, David B.
    [J]. EXPERT REVIEW OF ANTICANCER THERAPY, 2014, 14 (09) : 1001 - 1005
  • [7] Time to chemotherapy in ovarian cancer: Compliance with ovarian cancer quality indicators at a National Cancer Institute-designated comprehensive cancer center
    ElNaggar, A. C.
    Liang, M. I.
    O'Malley, D. M.
    Hade, E. M.
    Copeland, L. J.
    Fowler, J. M.
    Salani, R.
    Backes, F. J.
    Cohn, D. E.
    [J]. GYNECOLOGIC ONCOLOGY, 2017, 145 : 152 - 153
  • [8] Framework for Implementing and Tracking a Molecular Tumor Board at a National Cancer Institute-Designated Comprehensive Cancer Center
    Jain, Neha M.
    Schmalz, Lauren
    Cann, Christopher
    Holland, Adara
    Osterman, Travis
    Lang, Katie
    Wiesner, Georgia L.
    Pal, Tuya
    Lovly, Christine
    Stricker, Thomas
    Micheel, Christine
    Balko, Justin M.
    Johnson, Douglas B.
    Park, Ben Ho
    Iams, Wade
    [J]. ONCOLOGIST, 2021, 26 (11): : E1962 - E1970
  • [9] Patterns of Care for Non-Small-Cell Lung Cancer at an Academic Institution Affiliated With a National Cancer Institute-Designated Cancer Center
    Nguyen, Kim-Son H.
    Sanford, Rachel A.
    Huberman, Mark S.
    Goldstein, Michael A.
    McDonald, Danielle M.
    Farquhar, Mary
    Gangadharan, Sidharta P.
    Kent, Michael S.
    Michaud, Gaetane
    Majid, Adnan
    Berman, Stuart M.
    Aronovitz, Joseph A.
    Nedea, Elena A.
    Boiselle, Phillip M.
    Cohen, David W.
    Kobayashi, Susumu
    Costa, Daniel B.
    [J]. JOURNAL OF ONCOLOGY PRACTICE, 2012, 8 (01) : 57 - 62
  • [10] Adherence to postresection colorectal cancer surveillance at National Cancer Institute-designated Comprehensive Cancer Centers
    Kupfer, Sonia S.
    Lubner, Sam
    Coronel, Emmanuel
    Pickhardt, Perry J.
    Tipping, Matthew
    Graffy, Peter
    Keenan, Eileen
    Ross, Eric
    Li, Tianyu
    Weinberg, David S.
    [J]. CANCER MEDICINE, 2018, 7 (11): : 5351 - 5358